03.04.2018 Views

BusinessDay 03 Apr 2018

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BUSINESS DAY<br />

NEWS YOU CAN TRUST I TUESDAY 04 APRIL <strong>2018</strong><br />

C002D5556<br />

Insight<br />

Dangote Cement remains quality, but stretched<br />

We increase<br />

our Dangote<br />

Cement TP<br />

by 20% to<br />

NGN257<br />

(from NGN214) as we now<br />

include sea-based clinker exports<br />

to West African countries<br />

from 2019 and increase our<br />

long-term growth rate to 9%<br />

(from 6%), incorporating our<br />

SSA economist’s revised 2019<br />

Nigeria GDP growth forecast<br />

of 3%. On the back of this, we<br />

upgrade our rating to HOLD<br />

(from Sell) as our TP now implies<br />

downside of 3%. We think<br />

Dangote is a quality name to<br />

hold in Sub-Saharan Africa<br />

(SSA) cement, supported by<br />

strong margins, a healthy balance<br />

sheet, pan-Africa exposure<br />

and the pick-up in growth<br />

in Nigeria (the largest cement<br />

market in SSA). Despite this,<br />

we think the valuation is full,<br />

trading on 16.4x <strong>2018</strong> P/E, a<br />

17% premium to peers, on our<br />

estimates.<br />

A good set of numbers<br />

DangCem released good<br />

FY17 results, in line with our<br />

estimates. In dollar terms,<br />

Nigeria EBITDA/t increased<br />

36% YoY to $85/t, from $59/t,<br />

supported by stronger cement<br />

prices and a lower cash cost<br />

per tonne. Group margins<br />

were up an encouraging 636<br />

bpts, although the Pan-Africa<br />

EBITDA margin came in below<br />

our estimate of 18%, at<br />

15%, owing to currency devaluation<br />

in Ethiopia, start-up<br />

costs in Congo and significant<br />

losses in Tanzania in 4Q17. We<br />

expect a c. 10% price increase<br />

in Ethiopia to c. $90/t to offset<br />

this devaluation and believe<br />

that once gas is provided for<br />

the Tanzanian plant (expected<br />

in May), the average margin<br />

in Pan-Africa will be in the<br />

low 20%s. Positively, Nigerian<br />

cement exports by road more<br />

than doubled to 0.7mnt and<br />

DangCem is still on track to<br />

begin clinker shipment to<br />

other West African countries<br />

by year-end. This, in addition<br />

to strong cement growth,<br />

should support margins as<br />

fixed costs per tonne fall on<br />

higher utilisation, due to the<br />

export of c. 2-3mnt of clinker<br />

in 2019.<br />

Expecting a stronger <strong>2018</strong><br />

Management has guided<br />

for strong growth of 7-10% in<br />

the Nigerian cement market,<br />

in line with our 9% estimated<br />

market growth – supported by<br />

government contractors resuming<br />

work and an increase<br />

in individual demand. According<br />

to management, demand<br />

in the Nigerian market picked<br />

up strongly from February<br />

<strong>2018</strong> and has continued into<br />

March. We think <strong>2018</strong> will be<br />

a good year for the Nigerian<br />

cement market boosted by<br />

stronger prices and growth, in<br />

line with management’s guidance<br />

to keep cement prices<br />

flat in the medium term. In<br />

Nigeria, the company’s longterm<br />

strategy is to be the sole<br />

supplier of clinker to West<br />

African countries beginning<br />

from 4Q18. For Pan-Africa,<br />

Senegal, Cameroon and Ethiopia<br />

remain strong markets<br />

and we believe resolving the<br />

significant losses ($2.5mn a<br />

month) in Tanzania will be<br />

the biggest upside. DangCem<br />

plans to raise a local bond<br />

of NGN50bn (NGN300bn<br />

approved by SEC) for refinancing,<br />

and a eurobond for<br />

expansionary capex subject to<br />

approval by the board.<br />

Upgrading to a HOLD<br />

We upgrade DangCem<br />

to HOLD on the back of a<br />

positive growth outlook for<br />

the company. Our TP implies<br />

3% downside but our FY18E<br />

dividend yield of 5% implies<br />

a total return of 2%. The main<br />

upside risk to our estimates include<br />

a stronger contribution<br />

to margins from Pan-Africa<br />

and a stronger cement price<br />

than our estimates. Potential<br />

downside risks are a decline<br />

in Nigerian cement prices and<br />

continued poor operations in<br />

Tanzania, Congo and Ghana.<br />

Dangote is trading at a <strong>2018</strong><br />

P/E and EV/EBITDA of 16.4%<br />

and 10.9% a 17% and 15%<br />

premium to frontier peers, on<br />

our estimates.<br />

Valuation summary<br />

Tax reversals...but this<br />

could have been avoided<br />

In its FY17 results DangCem<br />

reversed the tax benefits<br />

(NGN44bn) taken in 2016 on<br />

some production lines. These<br />

are still awaiting approval to be<br />

granted initial pioneer status.<br />

The pioneer status extension<br />

on other production lines,<br />

also awaiting approval, were<br />

not reversed (NGN24bn). We<br />

The historical tax benefits inflated 2016<br />

earnings and we would have preferred<br />

a more conservative approach<br />

in accounting for this. That said, we<br />

are confident that the approvals will<br />

ultimately be granted given the extent<br />

of DangCem’s investment in Nigeria.<br />

We believe the delay was due to the<br />

change in government<br />

believe that the tax benefits<br />

derived from both the extension<br />

of pioneer status and<br />

initial pioneer status should<br />

have remained outside the<br />

group’s results until approval<br />

is granted. The historical tax<br />

benefits inflated 2016 earnings<br />

and we would have preferred<br />

a more conservative approach<br />

in accounting for this. That<br />

said, we are confident that<br />

the approvals will ultimately<br />

be granted given the extent<br />

of DangCem’s investment in<br />

Nigeria. We believe the delay<br />

was due to the change in government.<br />

Changes to estimates<br />

We increase our TP by 20%<br />

to NGN257 given: 1) the inclusion<br />

of sea-based clinker exports<br />

from 2019; 2) our higher<br />

terminal growth rate of 9%<br />

(from 6%); 3) a lower cash<br />

cost per tonne in the Nigerian<br />

business; and 4) a 22% drop<br />

in DangCem’s net debt. This<br />

increases our five-year CAGR<br />

EPS by 7% from an average of<br />

NGN24.5 from NGN23.0.<br />

Given our more positive<br />

view on the outlook for the Nigerian<br />

cement market and as<br />

such stronger growth in DangCem<br />

we upgrade DangCem<br />

to a HOLD rating (from Sell).<br />

Dangote’s current <strong>2018</strong>E<br />

P/E of 16.4x is at a 17% premium<br />

to the frontier market peer<br />

average of 14.0x. On <strong>2018</strong>E EV/<br />

EBITDA, DangCem is trading<br />

at 10.9x, a 15% premium to<br />

frontier peers.<br />

We value Dangote on an<br />

SoTP approach. We use a fiveyear<br />

DCF model for its Nigerian<br />

operations and 2019E EV/<br />

EBITDA multiples of 9x and 7x<br />

for its SSA and South African<br />

operations, respectively.<br />

Source: Company data,<br />

Renaissance Capital estimates<br />

Potential upside risks to<br />

our TP include: 1) a stronger<br />

contribution to margins and<br />

EV from operations outside<br />

Nigeria; 2) volumes in Nigeria<br />

outperforming our estimates;<br />

and 3) stronger cement prices<br />

in Nigeria than our estimates.<br />

Potential downside risks are:<br />

1) a decline in Nigerian cement<br />

prices; 2) continued<br />

operational difficulties in Tanzania,<br />

Congo and Ghana; and<br />

3) weaker cement volume<br />

growth in the Nigerian market.<br />

Disclosures appendix<br />

Analysts certification<br />

This research report has<br />

been prepared by the research<br />

analyst(s), whose name(s)<br />

appear(s) on the front page of<br />

this document, to provide back-<br />

ground information about the<br />

issuer or issuers (collectively,<br />

the “Issuer”) and the securities<br />

and markets that are the subject<br />

matter of this report. Each research<br />

analyst hereby certifies<br />

that with respect to the Issuer<br />

and such securities and markets,<br />

this document has been<br />

produced independently of<br />

the Issuer and all the views expressed<br />

in this document accurately<br />

reflect his or her personal<br />

views about the Issuer and any<br />

and all of such securities and<br />

markets. Each research analyst<br />

and/or persons connected<br />

with any research analyst may<br />

have interacted with sales and<br />

trading personnel, or similar,<br />

for the purpose of gathering,<br />

synthesizing and interpreting<br />

market information. If the date<br />

of this report is not current, the<br />

views and contents may not<br />

reflect the research analysts’<br />

current thinking.<br />

Each research analyst also<br />

certifies that no part of his or<br />

her compensation was, or will<br />

be, directly or indirectly related<br />

to the specific ratings,<br />

forecasts, estimates, opinions<br />

or views in this research report.<br />

Research analysts’ compensation<br />

is determined based upon<br />

activities and services intended<br />

to benefit the investor clients<br />

of Renaissance Securities (Cyprus)<br />

Limited and any of its<br />

affiliates (“Renaissance Capital”).<br />

Like all of Renaissance<br />

Capital’s employees, research<br />

analysts receive compensation<br />

that is impacted by overall Renaissance<br />

Capital profitability,<br />

which includes revenues from<br />

other business units within<br />

Renaissance Capital.<br />

Important issuer disclosures<br />

Important issuer disclosures<br />

outline currently known<br />

conflicts of interest that may<br />

unknowingly bias or affect the<br />

objectivity of the analyst(s) with<br />

respect to an issuer that is the<br />

subject matter of this report.<br />

Disclosure(s) apply to Renaissance<br />

Securities (Cyprus) Limited<br />

or any of its direct or indirect<br />

subsidiaries or affiliates (which<br />

are individually or collectively<br />

referred to as “Renaissance<br />

Capital”) with respect to any<br />

issuer or the issuer’s securities.<br />

Investment ratings<br />

Investment ratings may be<br />

determined by the following<br />

standard ranges: Buy (expected<br />

total return of 15% or more);<br />

Hold (expected total return<br />

of 0-15%); and Sell (expected<br />

negative total return). Standard<br />

ranges do not always apply to<br />

emerging markets securities and<br />

ratings may be assigned on the<br />

basis of the research analyst’s<br />

knowledge of the securities.<br />

Investment ratings are a<br />

function of the research analyst’s<br />

expectation of total return<br />

on equity (forecast price<br />

appreciation and dividend yield<br />

within the next 12 months,<br />

unless stated otherwise in the<br />

report). Investment ratings are<br />

determined at the time of initiation<br />

of coverage of an issuer of<br />

equity securities or a change in<br />

target price of any of the issuer’s<br />

equity securities. At other times,<br />

the expected total returns may<br />

fall outside of the range used<br />

at the time of setting a rating<br />

because of price movement<br />

and/or volatility. Such interim<br />

deviations will be permitted<br />

but will be subject to review by<br />

Renaissance Capital’s Research<br />

Management.<br />

Where the relevant issuer<br />

has a significant material event<br />

with further information pending<br />

or to be announced, it may<br />

be necessary to temporarily<br />

place the investment rating Under<br />

Review. This does not revise<br />

the previously published rating,<br />

but indicates that the analyst is<br />

actively reviewing the investment<br />

rating or waiting for sufficient<br />

information to re-evaluate<br />

the analyst’s expectation of total<br />

return on equity.<br />

Where coverage of the<br />

relevant issuer is due to be<br />

maintained by a new analyst, on<br />

a temporary basis the relevant<br />

issuer will be rated as Coverage<br />

in Transition. Previously published<br />

investment ratings should<br />

not be relied upon as they may<br />

not reflect the new analysts’<br />

current expectations of total<br />

return. While rated as Coverage<br />

in Transition, Renaissance<br />

Capital may not always be able<br />

to keep you informed of events<br />

or provide background information<br />

relating to the issuer.<br />

If issuing of research is restricted<br />

due to legal, regulatory<br />

or contractual obligations publishing<br />

investment ratings will be<br />

Restricted. Previously published<br />

investment ratings should not<br />

be relied upon as they may<br />

no longer reflect the analysts’<br />

current expectations of total<br />

return. While restricted, the<br />

analyst may not always be able<br />

to keep you informed of events<br />

or provide background information<br />

relating to the issuer.<br />

Where Renaissance Capital<br />

has neither reviewed nor<br />

revised its investment ratings<br />

on the relevant issuer for a<br />

period of 180 calendar days,<br />

coverage shall be discontinued.<br />

Where Renaissance Capital<br />

has not provided coverage of<br />

an issuer for a period of 365<br />

calendar days, coverage shall be<br />

discontinued.<br />

Where Renaissance Capital<br />

has not expressed a commitment<br />

to provide continuous<br />

coverage and/or an expectation<br />

of total return, to keep you<br />

informed, analysts may prepare<br />

reports covering significant<br />

events or background information<br />

without an investment rating<br />

(Not Covered).<br />

Your decision to buy or sell<br />

a security should be based upon<br />

your personal investment objectives<br />

and should be made only<br />

after evaluating the security’s<br />

expected performance and risk.<br />

Renaissance Capital reserves<br />

the right to update or amend its<br />

investment ratings in any way and<br />

at any time it determines.<br />

Source: Renaissance Capital<br />

Published by BusinessDAY Media Ltd., The Brook, 6 Point Road, GRA, Apapa, Lagos. Ghana Office: Business Day Ghana Ltd; ABC Junction, near Guinness Ghana Limited, Achimota – Accra, Ghana.<br />

Tel: +233243226596: email: mail@businessdayonline.com Advert Hotline: 08116759801, 08082496194. Subscriptions 01-2950687, 07045792677. Newsroom: 08169609331<br />

Editor: Anthony Osae-Brown. All correspondence to BusinessDAY Media Ltd., Box 1002, Festac Lagos. ISSN 1595 - 8590.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!